This grant, part of the HEAL Initiative, is for developmental and exploratory research aimed at addressing significant oral health disparities and complications in individuals undergoing pharmacotherapy for Opioid Use Disorders (OUDs). The primary purpose is to deepen our understanding of the complex biology, natural history, and progression of these specific oral complications. Furthermore, it seeks to investigate critical factors such as access to care, socioeconomic determinants, and other systemic challenges that contribute to the onset and advancement of dental and oral diseases in the OUD patient population. This funding will support vital research designed to improve overall health outcomes and quality of life for those managing OUDs.
Opportunity ID: 342949
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DE-23-016 |
| Funding Opportunity Title: | HEAL Initiative: Oral Complications Arising from Pharmacotherapies to Treat Opioid Use Disorders (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.121 — Oral Diseases and Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 03, 2022 |
| Last Updated Date: | Aug 03, 2022 |
| Original Closing Date for Applications: | Feb 14, 2023 |
| Current Closing Date for Applications: | Feb 14, 2023 |
| Archive Date: | Mar 22, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts For profit organizations other than small businesses County governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education State governments Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to solicit developmental/exploratory research to better understand the biology, natural history, and directionality of oral complications associated with pharmacotherapies used to treat opioid use disorders (OUDs). Further, this FOA will support research to explore access to care and other challenges that may contribute to dental and oral disease onset and progression in people with OUD. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DE-23-016.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 342949 Full Announcement-RFA-DE-23-016 -> RFA-DE-23-016-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276274 | Dec 16, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278169 | Dec 16, 2022 | Feb 14, 2023 | View |
Package 1
Mandatory forms
342949 RR_SF424_5_0-5.0.pdf
342949 PHS398_CoverPageSupplement_5_0-5.0.pdf
342949 RR_OtherProjectInfo_1_4-1.4.pdf
342949 PerformanceSite_4_0-4.0.pdf
342949 RR_KeyPersonExpanded_4_0-4.0.pdf
342949 PHS398_ResearchPlan_4_0-4.0.pdf
342949 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342949 RR_Budget_3_0-3.0.pdf
342949 RR_SubawardBudget30_3_0-3.0.pdf
342949 PHS398_ModularBudget_1_2-1.2.pdf
342949 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
342949 RR_SF424_5_0-5.0.pdf
342949 PHS398_CoverPageSupplement_5_0-5.0.pdf
342949 RR_OtherProjectInfo_1_4-1.4.pdf
342949 PerformanceSite_4_0-4.0.pdf
342949 RR_KeyPersonExpanded_4_0-4.0.pdf
342949 PHS398_ResearchPlan_5_0-5.0.pdf
342949 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342949 RR_Budget_3_0-3.0.pdf
342949 RR_SubawardBudget30_3_0-3.0.pdf
342949 PHS398_ModularBudget_1_2-1.2.pdf
342949 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
